07.01.2016
- Germany’s Merck KGaA and Pfizer of the US are collaborating with US biopharmaceutical company Syndax to evaluate a combination of avelumab and entinostat to treat advanced ovarian...
23.12.2015
- Bayer is likely to seek a major life sciences M&A deal in the next few years, banking sources have told the news agency Reuters. The German group’s absence from a recent wave of...
11.12.2015
- Catalent Pharma Solutions has signed an exclusive long term supply agreement with Pfizer to produce over-the-counter heartburn treatment, Nexium 24HR (esomeprazole), branded as...
24.11.2015
- Confirming rumors of the past weekend, US pharmaceutical giant Pfizer has said it will buy drugmaker Allergan for $160 million and move its headquarters to Ireland. The ever faster...
19.11.2015
- A further regulatory milestone has been achieved by Merck KGaA and Pfizer after the US Food and Drug Administration (FDA) designated their potential skin cancer treatment avelumab...
30.10.2015
- US pharmaceutical giant Pfizer and Ireland-domiciled former US drugmaker Allergan (in its current incarnation a combined Allergan and Actavis) have confirmed they are in “friendly”...
22.10.2015
- Six international drugmakers, led by GlaxoSmithKline (GSK) and including Johnson & Johnson, Biogen, Eli Lilly, Pfizer and Takeda, have joined forces with the UK Department of...
08.10.2015
- After previously receiving Orphan Drug status for avelumab, an investigational fully human anti-PD-L1 IgG1 monoclonal antibody to treat the rare and aggressive skin cancer Merkel...